Neurological Deterioration in Ischemic Stroke Management

Neurological deterioration in ischaemic stroke describes the progressive worsening of clinical status following initial onset. Early neurological deterioration, typically defined as an increase of two or more points on a standard stroke severity scale within the first 72 hours, affects up to 30 % of patients. Multiple interrelated mechanisms contribute to this phenomenon, including expansion of the infarct core, failure of collateral perfusion, haemodynamic instability, blood–brain barrier disruption and local inflammatory responses. Patients who experience deterioration exhibit poorer functional outcomes and higher mortality. Risk stratification relies on clinical indicators such as initial stroke severity, lesion topography and systemic factors including hyperglycaemia and inflammatory biomarkers. Advances in multimodal imaging permit the dynamic assessment of perfusion deficits and microvascular integrity, while blood-based biomarkers are under investigation for early prediction of decline. Current management strategies focus on optimising reperfusion, stabilising cerebral haemodynamics and tailoring secondary prevention. Emerging precision-medicine approaches integrate clinical, imaging and molecular data to identify individuals at high risk of deterioration and to guide timely interventions, with the ultimate aim of improving long-term recovery and reducing the global burden of stroke.

Research from Nature Portfolio

Recent studies have used advanced molecular imaging to characterise the spatiotemporal dynamics of neuroinflammation following reperfusion therapy. High-resolution positron emission tomography tracers targeting microglial activation have revealed that early proinflammatory responses correlate with regions of microvascular obstruction and secondary tissue injury, suggesting a window for targeted anti-inflammatory intervention. In parallel, proteomic profiling of serial blood samples from acute stroke patients has identified a signature panel of neurofilament light chains and endothelial microparticles that predicts early neurological decline with high accuracy, offering potential for minimally invasive risk stratification in clinical practice.

Neurological Deterioration in Ischemic Stroke Management publication trend

The graph below shows the total number of articles in neurological deterioration in ischemic stroke management across all publications each year (not limited to Nature Index journals).

Technical terms

Early neurological deterioration (END): A clinical worsening defined as a specified increase in stroke severity score within a fixed early time frame, often 72 hours.

Ischaemic penumbra: Tissue at risk surrounding the infarct core with compromised perfusion but potentially salvageable if reperfused promptly.

Nomogram: A statistical tool that combines multiple predictors into a graphical model to estimate the probability of a clinical event.

Branch atheromatous disease (BAD): A subtype of subcortical infarction caused by atherosclerotic plaque at the origin of perforating arteries.

National Institutes of Health Stroke Scale (NIHSS): A standardised tool for quantifying neurological impairment in stroke patients.

References

1. A Novel Nomogram Integrating Retinal Microvasculature and Clinical Indicators for Individualized Prediction of Early Neurological Deterioration in Single Subcortical Infarction. CNS Neuroscience & Therapeutics (2025).
2. Hemodynamic Factors May Play a Critical Role in Neurological Deterioration Occurring within 72 hrs after Lacunar Stroke. PLOS ONE (2014).
3. Efficacy and Safety of Intravenous Thrombolysis on Acute Branch Atheromatous Disease: A Retrospective Case–Control Study. Frontiers in Neurology (2020).